Fleisher-Berkovich, S.; Battaglia, V.; Baratta, F.; Brusa, P.; Ventura, Y.; Sharon, N.; Dahan, A.; Collino, M.; Ben-Shabat, S.
An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release. Int. J. Mol. Sci. 2023, 24, 16254.
https://doi.org/10.3390/ijms242216254
AMA Style
Fleisher-Berkovich S, Battaglia V, Baratta F, Brusa P, Ventura Y, Sharon N, Dahan A, Collino M, Ben-Shabat S.
An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release. International Journal of Molecular Sciences. 2023; 24(22):16254.
https://doi.org/10.3390/ijms242216254
Chicago/Turabian Style
Fleisher-Berkovich, Sigal, Veronica Battaglia, Francesca Baratta, Paola Brusa, Yvonne Ventura, Nitzan Sharon, Arik Dahan, Massimo Collino, and Shimon Ben-Shabat.
2023. "An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release" International Journal of Molecular Sciences 24, no. 22: 16254.
https://doi.org/10.3390/ijms242216254
APA Style
Fleisher-Berkovich, S., Battaglia, V., Baratta, F., Brusa, P., Ventura, Y., Sharon, N., Dahan, A., Collino, M., & Ben-Shabat, S.
(2023). An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release. International Journal of Molecular Sciences, 24(22), 16254.
https://doi.org/10.3390/ijms242216254
